Bausch Health Cos Inc (NYSE: BHC) has reported earnings for its second fiscal quarter (ending June 30) of $0.03 versus $0.07 for the same period a year ago. For the latest four quarters through June 30, E.P.S. were $-1.28 versus $-0.51 for the same period a year ago.
Recent Price Action
Bausch Health Cos Inc (NYSE: BHC) stock increased 1.2% on 8/1/24. The shares closed at $6.10. Trading volume in this advance was normal. The stock has been weak relative to the market over the last nine months but has risen 5.0% during the last week.
Current PriceTarget Research Rating
BHC is expected to be an important Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Bausch Health is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment